Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001808968-26-000005

CHIEF EXECUTIVE OFFICER sold 8,165 shares at an average $77.15 ($629,895)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-06 Sale : show line 1 in the form 10b5-1 −5,149 $76.95 $396,216 399,983 D
2026-01-07 Sale : show line 2 in the form 10b5-1 −3,016 $77.48 $233,680 396,967 D
Open-market sales · 8,165 sh · avg $77.15 · $629,895
Loading xslF345X05/form4-01082026_050118.xml…